Clozapine-induced Insulin-resistant Hyperglycemia in a Diabetic Patient

Clozapine is superior to all other antipsychotics in treatment-resistant schizophrenia. However, metabolic side effects are common while treating patients with clozapine. Administering clozapine in a patient who already is diabetic involves careful weighing of risks and benefits. Here, we report our...

Descripción completa

Detalles Bibliográficos
Autores principales: Chathoth, Vijay, Ramamurthy, Parthasarathy, Solomon, Susan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Medknow Publications & Media Pvt Ltd 2018
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6065131/
https://www.ncbi.nlm.nih.gov/pubmed/30093751
http://dx.doi.org/10.4103/IJPSYM.IJPSYM_373_17

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6065131/
https://www.ncbi.nlm.nih.gov/pubmed/30093751
http://dx.doi.org/10.4103/IJPSYM.IJPSYM_373_17

Ejemplares similares